A RANDOMIZED SINGLE-CENTER PHASE-III TRIAL WITH PIPERACILLIN SULBACTAM AND CEFTAZIDIME AS FIRST-LINE TREATMENT FOR 103 FEBRILE EPISODES IN PATIENTS WITH SEVERE NEUTROPENIA/

Citation
T. Lange et al., A RANDOMIZED SINGLE-CENTER PHASE-III TRIAL WITH PIPERACILLIN SULBACTAM AND CEFTAZIDIME AS FIRST-LINE TREATMENT FOR 103 FEBRILE EPISODES IN PATIENTS WITH SEVERE NEUTROPENIA/, British Journal of Haematology, 102(1), 1998, pp. 94-95
Citations number
NO
Categorie Soggetti
Hematology
ISSN journal
00071048
Volume
102
Issue
1
Year of publication
1998
Supplement
S
Pages
94 - 95
Database
ISI
SICI code
0007-1048(1998)102:1<94:ARSPTW>2.0.ZU;2-1